Paper Details 
Original Abstract of the Article :
Glutathione S-transferases (GST) represent a large family of Phase II detoxification enzymes widely expressed in animals and plants. These enzymes catalyse the conjugation of glutathione with some endogenous molecules and a broad range of exogenous substrates including various anticancer drugs. Due ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1517/14728222.5.4.477

データ提供:米国国立医学図書館(NLM)

Glutathione S-transferases: Emerging Oasis in the Desert of Cancer Treatment

Cancer, a complex and multifaceted disease, often presents challenges in treatment. This review examines the potential of glutathione S-transferases (GSTs), a family of detoxification enzymes, as emerging therapeutic targets. GSTs play a crucial role in drug resistance, and their overexpression in tumors has been linked to poor prognosis. The authors discuss the development of GST inhibitors and prodrugs as strategies to enhance the therapeutic index of cancer treatments. While early-generation inhibitors had limitations, newer approaches, such as glutathione analogues, offer promising potential for targeted drug delivery and improved efficacy. This review highlights the ongoing research efforts to exploit GSTs as therapeutic targets in the fight against cancer.

A Shifting Landscape: GSTs in Cancer Treatment

The review, like a journey through a desert landscape, reveals the dynamic nature of cancer research. The exploration of GSTs as therapeutic targets offers a promising new avenue for developing more effective and targeted treatments. This research underscores the importance of continued innovation and the pursuit of novel strategies to combat cancer.

Navigating the Sands of Cancer Treatment: A Multifaceted Approach

If you are diagnosed with cancer, it is crucial to consult with a qualified oncologist to discuss all available treatment options. New and emerging therapies are constantly being developed, and personalized approaches are essential for optimal outcomes. Remember, navigating the desert of cancer treatment requires a collaborative approach, with a skilled guide and a unwavering spirit of hope.

Dr.Camel's Conclusion

This review highlights the potential of GSTs as emerging therapeutic targets in the fight against cancer. The development of GST inhibitors and prodrugs offers promising new avenues for targeted drug delivery and improved efficacy. Remember, the journey through cancer treatment is best navigated with a knowledgeable guide and a relentless pursuit of new horizons.

Date :
  1. Date Completed n.d.
  2. Date Revised 2019-11-20
Further Info :

Pubmed ID

12540261

DOI: Digital Object Identifier

10.1517/14728222.5.4.477

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.